Protect II, A Prospective, Multicenter Randomized Controlled Trial (PROTECT II)

This study has been terminated.
(Futility on primary endpoint.Study confounded by statistically significant differences between the two arms re: atherectomy, duration of support.)
Information provided by:
Abiomed Inc. Identifier:
First received: November 19, 2007
Last updated: March 18, 2011
Last verified: March 2011